ArticleActa pharmacologica Sinica2021

Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.

Wen-Li Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.